Correlates of total plasma homocysteine: Folic acid, copper, and cervical dysplasia

Nutrition

Volumn 16, Issue 6, 2000, Pages 411-416

  Thomson, Stephen W ^a   Heimburger, Douglas C ^a   Cornwell, Phillip E ^a   Turner, Malcolm E ^a   Sauberlich, Howerde E ^a   Fox, Liesl M ^a   Butterworth, C E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cervical dysplasia; Copper; Folic acid; Homocysteine; Supplementation; Vitamin B12

Indexed keywords

ASCORBIC ACID; CAROTENOID; COPPER; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; HOMOCYSTEINE; IRON; ORAL CONTRACEPTIVE AGENT; POLYUNSATURATED FATTY ACID; PYRIDOXINE; RETINOL; ZINC;

AMINO ACID BLOOD LEVEL; ARTICLE; CANCER GRADING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ETHNOLOGY; FAT INTAKE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONTRACEPTIVES, ORAL; COPPER; DIET; DIETARY FATS; DIETARY SUPPLEMENTS; ERYTHROCYTES; ETHNIC GROUPS; FATTY ACIDS, UNSATURATED; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LINEAR MODELS; RISK FACTORS; VITAMIN B 12;

EID: 0034084762     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00284-7     Document Type: Article

References (35)

1. Kang S.-S., Wong P.W.K., Malinow M.R. Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Ann Rev Nutr. 12:1992;279.
2. Eikelboom J.W., Lonn E.E., Genest J. Jr, et al. Homocysteine and cardiovascular disease a critical review of the epidemiologic evidence. Ann Intern Med. 131:1999;363.
3. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 338:1998;1042.
4. Ridker P.M., Manson J.E., Buring J.E., et al. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA. 281:1999;1817.
5. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease. JAMA. 277:1997;1775.
6. Ubbink J.B., Vermaak W.J.H., Delport R., et al. Effective homocysteine metabolism may protect South African Blacks against coronary heart disease. Am J Clin Nutr. 62:1995;802.
7. Nygard O., Vollset S.E., Refsum H., et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA. 274:1995;1526.
8. Stampfer M.J., Malinow M.R., Willett W.C., et al. A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. physicians. JAMA. 268:1992;877.
9. Valentine R.J., Kaplan H.S., Green R., et al. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis a prospective controlled analysis. J Vasc Surg. 23:1996;53.
10. Perry I.J., Refsum H., Morris R.W., et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1995;1395.
11. Bostom A.G., Rosenberg I.H., Silbershatz H., et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons the Framingham Study. Ann Intern Med. 131:1999;352.
12. Selhub J., Jacques P.F., Bostom A.G., et al. Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population. J Nutr. 126:1996;1258. (S).
13. Selhub J., Miller J.W. The pathogenesis of homocysteinemia interruption of the coordinate regulation by S-adenosyl methionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr. 55:1992;131.
14. Butterworth C.E., Hatch K.D., Macaluso M., et al. Folate deficiency and cervical dysplasia. JAMA. 267:1992;528.
15. Butterworth C.E., Hatch K.D., Soong S.-J., et al. Oral folic acid supplementation for cervical dysplasia a clinical intervention trial. Am J Obstet Gynecol. 166:1992;803.
16. Brattstrom L. Vitamins as homocysteine-lowering agents. J Nutr. 126:1996;1276.
17. Scott J.M., Ghanta V., Herbert V. Trouble free microbiologic serum and red cell folate assays. Am J Med Technol. 40:1974;125.
18. 6. Clin Chem. 22:1976;327.
19. Kutnink M.A., Skala J.H., Sauberlich H.E., et al. Simultaneous determination of ascorbic acid, isoascorbic acid (erythorbic acid) and uric acid in human plasma by high performance liquid chromatography with amperometric detection. J Liq Chromatog. 8:1985;31.
20. Sunderman F.W. Jr. Atomic absorption spectrometry of trace metals in clinical pathology. Hum Pathol. 4:1973;549.
21. Olson A.D., Hamlin W.B. A new method for serum iron and total iron binding capacity by atomic absorption spectrophotometry. Clin Chem. 15:1969;438.
22. Cornwell P.E., Morgan S.L., Vaughn W.H. Modification of a high-performance liquid chromatographic method for assay of homocysteine in human plasma. J Chromatogr. 617:1993;136.
23. Ubbink J.B., Vermaak W.J.H., Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 565:1991;441.
24. Westgard J.O., Klee G.G. Quality assurance. Tietz N.W. Textbook of clinical chemistry. 1986;424 W.B. Saunders, Philadelphia.
25. Lussier-Cacan S., Xhignesse M., Piolot A., et al. Plasma total homocysteine in healthy subjects sex-specific relation with biological traits. Am J Clin Nutr. 64:1996;587.
26. Malinow M.R., Duell P.B., Hess D.L., et al. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 338:1998;1009.
27. Wilcken D.E.L., Dudman N.P.B., Tyrrell P.A., et al. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency possible implications for prevention of vascular disease. Metabolism. 37:1988;697.
28. 6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 298:1998;359.
29. Clemente C., Russo F., Caruso M.G., et al. Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times. Horm Metab Res. 24:1992;191.
30. Crews M.G., Taper L.J., Ritchey S.J. Effects of oral contraceptive agents on copper and zinc balance in young women. Am J Clin Nutr. 33:1980;1940.
31. Bethin K.E., Petrovic N., Ettinger M.J. Identification of a major hepatic copper binding protein as S-adenosylhomocysteine hydrolase. J Biol Chem. 270:1994;20698.
32. Hultberg B., Andersson A., Isaksson A. Copper ions differ from other thiol reactive metal ions in their effects on the concentration and redox status of thiols HeLa cell cultures. Toxicology. 117:1997;89.
33. Brattstrom L., Israelsson B., Norrving B., et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis. 81:1990;51.
34. National Research Council. Recommended dietary allowances, 10th ed. Washington, DC: National Academy Press, 1989.
35. 12 deficiency. J Nutr. 126:1996;1266S.